Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • About HHS
  • MAHA in Action
  • Programs & Services
  • Grants & Contracts
  • Laws & Regulations
  • Radical Transparency
Breadcrumb
  1. Home
  2. Press Room
  3. HHS Revives Task Force on Safer Childhood Vaccines
  • Press Room
  • HHS Live
FOR IMMEDIATE RELEASE
August 14, 2025
Contact: HHS Press Office
202-690-6343
Submit a Request for Comment

HHS Revives Task Force on Safer Childhood Vaccines

WASHINGTON — The U.S. Department of Health and Human Services (HHS) today announced the reinstatement of the Task Force on Safer Childhood Vaccines, a federal panel created by Congress to improve the safety, quality, and oversight of vaccines administered to American children.

"By reinstating this Task Force, we are reaffirming our commitment to rigorous science, continuous improvement, and the trust of American families," said National Institutes of Health (NIH) Director Jay Bhattacharya. "NIH is proud to lead this effort to advance vaccine safety and support innovation that protects children without compromise."

The original Task Force was disbanded in 1998, and today's action reaffirms the Department's commitment towards continuous improvement in childhood vaccine safety oversight. The Task Force is represented by senior leadership from NIH, the Food and Drug Administration, and the Centers for Disease Control and Prevention. The NIH Director will serve as Chairman of the Task Force.

The Task Force will work closely with the Advisory Commission on Childhood Vaccines to produce regular recommendations focused on:

  • The development, promotion, and refinement of childhood vaccines that result in fewer and less serious adverse reactions than those vaccines currently on the market.
  • Improvements in vaccine development, production, distribution, and adverse reaction reporting — along with supporting research to make vaccines safer.

HHS will transmit its first formal report to Congress within two years, with updates every two years thereafter.

###
Note: All HHS press releases, fact sheets and other news materials are available in our Press Room.
Like HHS on Facebook, follow HHS on X @HHSgov, @SecKennedy, and sign up for HHS Email Updates.
Last revised: August 14, 2025

Submit a request for comment

For media inquiries, please submit a request for comment.

Sign up to receive our press releases

Sign Up

Related Press Releases

  • Secretary Kennedy Visits Alaska to Highlight Tribal and Rural Health Priorities

    • August 13, 2025 Press Release
  • HHS Winds Down mRNA Vaccine Development Under BARDA

    • August 5, 2025 Press Release
  • FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks

    • July 31, 2025 Press Release
Content created by ASPA Press Office
Content last reviewed August 14, 2025
Back to top

Subscribe to Email Updates

Receive the latest updates from the Secretary and Press Releases.

Subscribe
  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy
HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

Follow HHS

Follow Secretary Kennedy